Merck (MRK) Acquisitions (2009 - 2026)

Merck (MRK) has reported Acquisitions for 15 consecutive years, with $8.8 billion the latest figure, recorded in Q1 2026.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $8.8 billion in Q1 2026; TTM through Jun 2026 was $18.8 billion, a 2622.92% increase from a year earlier, with the FY2025 full-year figure at $10.0 billion, changed N/A from the prior year.
• Acquisitions was $8.8 billion for Q1 2026 at Merck, down from $10.0 billion in the prior quarter.
• Over five years, Acquisitions peaked at $10.0 billion in Q4 2025 and troughed at -$1.3 billion in Q4 2024.
• A 4-year average of $2.7 billion and a median of $598.0 million in 2024 frame the typical range for Acquisitions.
• The widest YoY moves for Acquisitions: up 12200.0% in 2022, down 234.44% in 2022.
• Over 4 years, Acquisitions stood at -$121.0 million in 2022, then plunged by 1010.74% to -$1.3 billion in 2024, then surged by 847.17% to $10.0 billion in 2025, then declined by 12.58% to $8.8 billion in 2026.
• The last three Acquisitions figures came in at $8.8 billion (Q1 2026), $10.0 billion (Q4 2025), and -$1.3 billion (Q4 2024), per Business Quant data.